Benign prostatic hyperplasia: clinical review

Content developed by MIMS Learning

INTRODUCTION

This resource covers the definition of benign prostatic hyperplasia (BPH), the role of prostate specific antigen (PSA) testing and how to initiate management. Key learning points for general practice nurses include clinical features, suitable examinations and potential side-effects of treatment.

LEARNING OBJECTIVES

After completing this module, you should be better able to:

• Explain the difference between BPH and benign prostatic enlargement (BPE)
• Be aware of the role of PSA in the diagnosis of BPH
• List the various drugs used to treat BPH
• Discuss with patients the prognosis associated with BPH
• Be aware of the evidence and guidelines associated with BPH

AUTHORS

Professor Christopher Chapple, Consultant urological surgeon, Sheffield Teaching Hospitals, Visiting professor, Sheffield Hallam University; and

Mr Altaf Mangera, Consultant urological surgeon, Sheffield Teaching Hospitals NHS Trust

This resource is provided at an advanced level by MIMS Learning. Read the article and reflect on what you have learned, then answer the test questions at the end.

Complete the resource to obtain a certificate of completion to include in your revalidation portfolio. You should record the time spent on this resource in your CPD log.

Complete the resource to obtain a certificate of completion to include in your revalidation portfolio.